255 related articles for article (PubMed ID: 38705362)
1. Development of nanomedicines for the treatment of Alzheimer's disease: Raison d'être, strategies, challenges and regulatory aspects.
Mazahir F; Alam MI; Yadav AK
Ageing Res Rev; 2024 Jul; 98():102318. PubMed ID: 38705362
[TBL] [Abstract][Full Text] [Related]
2. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for the treatment of Alzheimer's disease.
Gregori M; Masserini M; Mancini S
Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
[TBL] [Abstract][Full Text] [Related]
4. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease.
Ahmad MZ; Ahmad J; Amin S; Rahman M; Anwar M; Mallick N; Ahmad FJ; Rahman Z; Kamal MA; Akhter S
CNS Neurol Disord Drug Targets; 2014; 13(8):1315-24. PubMed ID: 25345516
[TBL] [Abstract][Full Text] [Related]
5. The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview.
Jakki SL; Senthil V; Yasam VR; Chandrasekar MJN; Vijayaraghavan C
Curr Drug Targets; 2018; 19(2):155-169. PubMed ID: 28606049
[TBL] [Abstract][Full Text] [Related]
6. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.
Taliyan R; Kakoty V; Sarathlal KC; Kharavtekar SS; Karennanavar CR; Choudhary YK; Singhvi G; Riadi Y; Dubey SK; Kesharwani P
J Control Release; 2022 Mar; 343():528-550. PubMed ID: 35114208
[TBL] [Abstract][Full Text] [Related]
7. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
8. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
Sharma HS; Castellani RJ; Smith MA; Sharma A
Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
[TBL] [Abstract][Full Text] [Related]
9. Brain Targeting Nanomedicines: Pitfalls and Promise.
Kakinen A; Jiang Y; Davis TP; Teesalu T; Saarma M
Int J Nanomedicine; 2024; 19():4857-4875. PubMed ID: 38828195
[TBL] [Abstract][Full Text] [Related]
10. Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's Disease.
Mazahir F; Yadav AK
CNS Neurol Disord Drug Targets; 2023; 22(4):477-499. PubMed ID: 35450536
[TBL] [Abstract][Full Text] [Related]
11. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
12. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.
Tosi G; Pederzoli F; Belletti D; Vandelli MA; Forni F; Duskey JT; Ruozi B
Prog Brain Res; 2019; 245():57-88. PubMed ID: 30961872
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
16. Advances in developing therapeutic strategies for Alzheimer's disease.
Nguyen TT; Nguyen TTD; Nguyen TKO; Vo TK; Vo VG
Biomed Pharmacother; 2021 Jul; 139():111623. PubMed ID: 33915504
[TBL] [Abstract][Full Text] [Related]
17. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
18. Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).
Binda A; Murano C; Rivolta I
Int J Nanomedicine; 2020; 15():6113-6135. PubMed ID: 32884267
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic compliance of nanomedicine in Alzheimer's disease.
Wilson B
Nanomedicine (Lond); 2011 Sep; 6(7):1137-9. PubMed ID: 21929451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
